Management of vaginitis

American Family Physician

Volumn 70, Issue 11, 2004, Pages

  Owen, Marion K ^a,c,d   Clenney, Timothy L ^b,c,e,f,g  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NAVAL HOSPITAL JACKSONVILLE   (United States)

^c School of Medicine ^*  (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^f UNIVERSITY OF SOUTH FLORIDA   (United States)

^g EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTOCONAZOLE; CLINDAMYCIN; CLOTRIMAZOLE; ESTROGEN; FLUCONAZOLE; GYNEZOLE; METRONIDAZOLE; MICONAZOLE; NYSTATIN; PYRROLE; TERCONAZOLE; TIOCONAZOLE;

BACTERIAL STRAIN; BACTERIUM CULTURE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA TROPICALIS; DIAGNOSTIC PROCEDURE; DNA PROBE; DRUG EFFICACY; DYSURIA; GARDNERELLA VAGINALIS; HUMAN; MICROSCOPY; REVIEW; TRICHOMONIASIS; VAGINA CANDIDIASIS; VAGINAL PRURITUS; VAGINITIS;

EID: 19744378820     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Kent HL. Epidemiology of vaginitis. Am J Obstet Gynecol 1991;165(4 pt 2):1168-76.
2. Schaaf VM, Perez-Stable E, Borchardt K. The limited value of symptoms and signs in the diagnosis of vaginal infections. Arch Intern Med 1990;150:1929-33.
3. Bornstein J, Lakovsky Y, Lavi I, Bar-Am A, Abramovici H. The classic approach to diagnosis of vulvovaginitis: a critical analysis. Infect Dis Obstet Gynecol 2001;9:105-11.
4. Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Holmes KK. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983;74:14-22.
5. Lurie S, Woliovitch I, Rotmensch S, Sadan O, Glezerman M. Value of vaginal culture in management of acute vaginitis. Arch Gynecol Obstet 2001;265:187-9.
6. Blake DR, Duggan A, Quinn T, Zenilman J, Joffe A. Evaluation of vaginal infections in adolescent women: can it be done without a speculum? Pediatrics 1998;102:939-44.
7. Sobel JD. Vaginitis. N Engl J Med 1997;337:1896-903.
8. Egan ME, Lipsky MS. Diagnosis of vaginitis. Am Fam Physician 2000;62:1095-104.
9. Sobel J. Bacterial vaginosis. Annu Rev Med 2000;51:349-56.
10. Sexually transmitted diseases treatment guideline 2002. Centers for Disease Control and Prevention MMWR Recomm Rep 2000;51(RR-6):1-80. Accessed online June 28, 2004, at: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5106a1.htm.
11. Hanson JM, McGregor JA, Hillier SL, Eschenbach DA, Kreutner AK, Galask RP, et al. Metronidazole for bacterial vaginosis. A comparison of vaginal gel vs. oral therapy. J Reprod Med 2000;45:889-96.
12. Mikamo H, Kawazoe K, Izumi K, Watanabe K, Ueno K, Tamaya T. Comparative study on vaginal or oral treatment of bacterial vaginosis. Chemotherapy 1997;43:60-8.
13. Fischbach F, Petersen EE, Weissenbacher ER, Martius J, Hosmann J, Mayer H. Efficacy of clindamycin vaginal cream versus oral metronidazole in the treatment of bacterial vaginosis. Obstet Gynecol 1993;82:405-10.
14. Schmitt C, Sobel JD, Meriwether C. Bacterial vaginosis: treatment with clindamycin cream versus oral metronidazole. Obstet Gynecol 1992;79:1020-3.
15. Ferris D, Litaker M, Woodward L, Mathis D, Hendrich J. Treatment of bacterial vaginosis: a comparison of oral metronidazole, metronidazole vaginal gel, and clindamycin vaginal cream. J Fam Pract 1995;41:443-9.
16. Ahmed-Jushuf I, Shahmanesh M, Arya OP. The treatment of bacterial vaginosis with a 3 day course of 2% clindamycin cream: results of a multicenter, double blind, placebo controlled trial. B V Investigators Group. Genitourin Med 1995;71:254-6.
17. French JI, McGregor JA, Draper D, Parker R, McFee J. Gestational bleeding, bacterial vaginosis, and common reproductive tract infections: risk for preterm birth and benefit of treatment. Obstet Gynecol 1999;93(5 pt 1):715-24.
18. McDonald HM, O'Loughlin JA, Vigneswaran R, Jolley PT, Harvey JA, Bof A, et al. Impact of metronidazole therapy on preterm birth in women with bacterial vaginosis flora (Gardnerella vaginalis): a randomised, placebo-controlled trial. Br J Obstet Gynaecol 1997;104:1391-7.
19. Kekki M, Kurki T, Pelkonen J, Kurkinen-Raty M, Cacciatore B, Paavonen J. Vaginal clindamycin in preventing preterm birth and peripartal infections in asymptomatic women with bacterial vaginosis: a randomized, controlled trial. Obstet Gynecol 2001;97(5 pt 1):643-8.
20. Duff P, Lee ML, Hillier SL, Herd LM, Krohn MA, Eschenbach DA. Amoxicillin treatment of bacterial vaginosis during pregnancy. Obstet Gynecol 1991;77:431-5.
21. McDonald H, Brocklehurst P, Parsons J, Vigneswaran R. Antibiotics for treating bacterial vaginosis during pregnancy. Cochrane Database Syst Rev 2004;(1):CD000262.
22. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin. Assessment of risk factors for preterm birth. Clinical management guidelines for obstetrician-gynecologists. Number 31, October 2001 (Replaces Technical Bulletin number 206, June 1995; Committee Opinion number 172, May 1996; Committee Opinion number 187, September 1997; Committee Opinion number 198, February 1998; and Committee Opinion number 251, January 2001). Obstet Gynecol 2001;98:709-16.
23. Screening for bacterial vaginosis: recommendations and rationale. Rockville, Md.: Agency for Healthcare Research and Quality. Accessed March 19, 2004, at: http://www.ahcpr.gov/clinic/ajpmsuppl/bvrr.htm.
24. Ugwumadu A, Manyonda I, Reid F, Hay P. Effect of early oral clindamycin on late miscarriage and preterm delivery in asymptomatic women with abnormal vaginal flora and bacterial vaginosis: a randomised controlled trial. Lancet 2003;361:983-8.
25. Caro-Paton T, Carvajal A, Martin de Diego I, Martin-Arias LH, Alvarez Requejo A, Rodriguez Pinilla E. Is metronidazole teratogenic? A meta-analysis. Br J Clin Pharmacol 1997;44:179-82.
26. Hallen A, Jarstrand C, Pahlson C. Treatment of bacterial vaginosis with lactobacilli. Sex Transm Dis 1992;19:146-8.
27. Reid G, Bruce AW, Fraser N, Heinemann C, Owen J, Henning B. Oral probiotics can resolve urogenital infections. FEMS Immunol Med Microbiol 2001;30:49-52.
28. Sobel JD, Faro S, Force RW, Foxman B, Ledger WJ, Nyirjesy PR, et al. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. Am J Obstet Gynecol 1998;178:203-11.
29. Eckert LO, Hawes SE, Stevens CE, Koutsky LA, Eschenbach DA, Holmes KK. Vulvovaginal candidiasis: clinical manifestations, risk factors, management algorithm. Obstet Gynecol 1998;92:757-65.
30. Ferris DG, Nyirjesy P, Sobel JD, Soper D, Pavleti c A, Litaker MS. Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis. Obstet Gynecol 2002;99:419-25.
31. Sobel JD, Brooker D, Stein GE, Thomason JL, Wermeling DP, Bradley B, et al. Single oral dose fluconazole compared with conventional clotrimazole topical therapy of Candida vaginitis. Fluconazole Vaginitis Study Group. Am J Obstet Gynecol 1995;172(4 pt 1):1263-8.
32. Sobel JD, Kapernick PS, Zervos M, Reed BD, Hooton T, Soper D, et al. Treatment of complicated Candida vaginitis: comparison of single and sequential doses of fluconazole. Am J Obstet Gynecol 2001;185:363-9.
33. Stein GE, Christensen S, Mummaw N. Comparative study of fluconazole and clotrimazole in the treatment of vulvovaginal candidiasis. DICP 1991;25:582-5.
34. Haefner HK. Current evaluation and management of vulvovaginitis. Clin Obstet Gynecol 1999;42:184-95.
35. Sobel JD. Recurrent vulvovaginal candidiasis (RVVC). Int J STD AIDS 2001;12(suppl 2):9.
36. Krieger JN, Tam MR, Stevens CE, Nielsen IO, Hale J, Kiviat NB, et al. Diagnosis of trichomoniasis. Comparison of conventional wet-mount examination with cytologic studies, cultures, and monoclonal antibody staining of direct specimens. JAMA 1988;259:1223-7.
37. Patel SR, Wiese W, Patel SC, Ohl C, Byrd JC, Estrada CA. Systematic review of diagnostic tests for vaginal trichomoniasis. Infect Dis Obstet Gynecol 2000;8:248-57.
38. Forna F, Gulmezoglu AM. Interventions for treating trichomoniasis in women. Cochrane Database Syst Rev 2004;(1):CD000218.
39. Wiese W, Patel SR, Patel SC, Ohl CA, Estrada CA. A meta-analysis of the Papanicolaou smear and wet mount for the diagnosis of vaginal trichomoniasis. Am J Med 2000;108:301-8.
40. DuBouchet L, Spence MR, Rein MF, Danzig MR, McCormack WM. Multicenter comparison of clotrimazole vaginal tablets, oral metronidazole, and vaginal suppositories containing sulfanilamide, aminacrine hydrochloride, and allantoin in the treatment of symptomatic trichomoniasis. Sex Transm Dis 1997;24:156-60.
41. Pearlman MD, Yashar C, Ernst S, Solomon W. An incremental dosing protocol for women with severe vaginal trichomoniasis and adverse reaction to metronidazole. Am J Obstet Gynecol 1996;174:934-6.
42. Sobel JD, Nyirjesy P, Brown W. Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis. Clin Infect Dis 2001;33:1341-6.
43. Nyirjesy P, Sobel JD, Weitz MV, Leaman DJ, Gelone SP. Difficult-to-treat trichomoniasis: results with paromomycin cream. Clin Infect Dis 1998;26:986-8.
44. Klebanoff MA, Carey JC, Hauth JC, Hillier SL, Nugent RP, Thorn EA, et al. Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. N Engl J Med 2001;345:487-93.
45. Pandit L, Ouslander JG. Postmenopausal vaginal atrophy and atrophic vaginitis. Am J Med Sci 1997;314:228-31.
46. Handa VL, Bachus KE, Johnston WW, Robboy SJ, Hammond CB. Vaginal administration of low-dose conjugated estrogens: systemic absorption and effects on the endometrium. Obstet Gynecol 1994;84:215-8.